Human health news

U of T Engineering is a leader in health care engineering. Together with doctors, medical researchers, policymakers and industry, we are helping people around the world live longer, healthier lives.

Professor Hai-Ling Margaret Cheng and her team have developed a more effective way to monitor cardiac stem cell therapy for treating heart disease. (Photo: Neil Ta)

Novel MRI approach gives heart failure patients new hope

June 1, 2016

A team of U of T biomedical engineering researchers has developed a novel method that will help shed new light on the effectiveness of stem cell therapy for heart failure patients

Left to right: Jaclyn Obermeyer, Malgosia Pakulska and Irja Elliott Donaghue, supervised by University Professor Molly Shoichet, are the first to show controlled release of proteins without encapsulating them in nanoparticles. (Credit: Marit Mitchell).

Simple attraction: U of T Engineering researchers control protein release from nanoparticles without encapsulation

May 27, 2016

Discovery stands to improve reliability and fabrication process for treatments for chronic conditions and serious injuries such as spinal cord damage and stroke

Shrey Sindhwani, Abdullah Syed and their supervisor, Professor Warren Chan, have modified and improved a technique to turn organs transparent, allowing them to track the locations of nanoparticles in the body. (Photo: Neil Ta)

Tracking nanoparticles with transparent organs to help fight cancer and other diseases

May 11, 2016

An improved technique for clarifying organs can help researchers learn how nanoparticles might be used to diagnose or treat diseases like cancer

Two innovative biomedical devices from the Hammers & Nails Initiative

April 29, 2016

Collaboration with SickKids leverages engineering design to solve everyday challenges in hospitals

Stefan Wilhelm is the lead author of a new review paper that shows less than one per cent of designer nanoparticles actually reach their intended target. The paper includes a coordinated long-term strategy to help increase this number in the future. (Photo: <a href="http://www.neilta.ca/">Neil Ta</a>)

How many nanoparticle-based drugs reach tumours? Less than one per cent, U of T Engineering study shows

April 26, 2016

“Reality check” meta-analysis published in Nature Reviews Materials reveals that only 0.7 per cent of designer nanoparticles reach their intended target

Professors Peter Herman and Milica Radisic have both received prestigious Collaborative Research and Training Experience (CREATE) grants from the Natural Sciences and Engineering Research Council (NSERC). (Credit: Michael T (left) and <a />Neil Ta</a> (right))

Two CREATE grants boost U of T Engineering research into optical technology and lab-grown human tissues

April 14, 2016

Two CREATE grants received by Professors Peter Herman and Milica Radisic will help train a new generation of experts in optical technologies and tissue engineering

Yonatan Lipsitz (BioMedE PhD candidate) is the lead author of a new paper that outlines a framework for manufacturing stem cell therapeutics, which he hopes will serve as a road map for the emerging industry. (Photo: Neil Ta)

An engineering road map for scaling up production of stem cell-derived treatments

April 7, 2016

Yonatan Lipsitz and his co-authors have created a road map for the emerging industry of manufacturing stem cell therapeutics

Professor Michael Sefton receives European Society for Biomaterials International Award

April 1, 2016

Award recognizes his scientific profile, major contributions to the field of biomaterials and longstanding active collaboration with the European scientific community

Dr. Malgosia Pakulska (pictured) and University Professor Molly Shoichet have outlined the best techniques for discovering molecules that will bind to proteins with the potential to treat conditions from stroke to heart disease. (Photo: Marit Mitchell)

Tailored protein binding opens possibilities for nerve, tissue treatments

March 17, 2016

Biomedical engineers at the University of Toronto review most promising ways to discover or design new binding partners for time-release protein treatments

Load more stories